Carasent AB (publ) (STO:CARA)
29.60
+1.00 (3.50%)
At close: Jul 31, 2025
Carasent AB Revenue
Carasent AB had revenue of 82.87M SEK in the quarter ending June 30, 2025, with 25.77% growth. This brings the company's revenue in the last twelve months to 311.34M, up 22.25% year-over-year. In the year 2024, Carasent AB had annual revenue of 275.26M with 12.27% growth.
Revenue (ttm)
311.34M
Revenue Growth
+22.25%
P/S Ratio
6.82
Revenue / Employee
1.59M
Employees
199
Market Cap
2.12B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 275.26M | 30.08M | 12.27% |
Dec 31, 2023 | 245.18M | 38.59M | 18.68% |
Dec 31, 2022 | 206.60M | 65.86M | 46.79% |
Dec 31, 2021 | 140.74M | 73.11M | 108.12% |
Dec 31, 2020 | 67.62M | 16.69M | 32.77% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Swedish Orphan Biovitrum AB | 26.97B |
Sectra AB | 3.31B |
Getinge AB | 35.50B |
Medicover AB | 25.22B |
Camurus AB | 2.27B |
Asker Healthcare Group AB | 15.88B |
Bonesupport Holding AB | 1.06B |
AddLife AB | 10.44B |